... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapyin non smallcelllung cancer: a meta-analysis ... cisplatin-teniposide in patients withadvanced non -small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol 1998, 16:2133-2141.7. ... paclitaxel plus gemcitabine in advanced non -small- cell lung cancer: a phase III trial of the European Organiza-tion for Research and Treatment of CancerLung Cancer Group – EORTC 08975. J Clin Oncol...
... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... ofdetecting EGFR mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor ... ofEGFR mutations in non -small- celllung cancer. Clin Cancer Res 2009,15:3023-3028.13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,Travis WD: Lung adenocarcinoma: modification...
... are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer are associated with smoking, although ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,97:1558-1563.11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. LungCancer 2009, 65:13-18.12. ... HPVs in Asian lung cancer is 35.7%. The authors concluded that HPV maybe the second leading cause of lungcancerafter cigar-ette smoking.Although studies of viral-related lungcancer havebeen...
... marker expression in tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... with adjuvant chemotherapy after complete resection of non -small celllung carcinoma. Cancer Res 2010,70:8288-98.19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: what now? J ThoracOncol ... required for cancer cell growth. PLoS One 2008, 3:e2557.16. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecularprofiles in lungcancer diagnosis and prognosis. CancerCell 2006,9:189-98.17....
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... for Research and Treatment of Cancer Quality-of-Life Questionnaire -Lung Cancer- 17items; EQ-5D: EuroQoL-5 Dimensions; HRQL: Health-related Quality of Life; NSCLC: Non -Small CellLung Can-cer;...
... gefitinib in non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients ... cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for ... in non -small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non -small- celllung cancer...
... responses. Failure to obtain a response after the first few cycles should notautomatically discourage to continue treatment. IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode ... Napoli1, Giacomo Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, ... induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2,...
... tolerance, an efficacy of thoracic irradiation in the combined modality treatment of limited stage smallcelllung cancer. Int J Radiat Oncol Biol Phys 1999, 43:39-45.31. Rancati T, Ceresoli ... of unresectable locally advanced non- small celllungcancer (NSCLC). Unfortunately, the longersurvival is achieved at the price of greater toxicity of the lung and the esophageal mucosa [3-5].* ... plus cisplatin or carboplatin in patients with locally advanced non -small- celllungcancer (NSCLC) and an increased risk of treatment complications: Preliminary results. Strahlenther Onkol 2003,...
... non -small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non -small celllung ... non -small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small celllung ... Lockett MA, Perez CA:Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non -small celllungcancer (NSCLC). Int J Radiat Oncol BiolPhys 1999, 45:323-329.25. Kwa SL,...
... Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients with stage IV NSCLC typically have a poor prognosis, ... Okunieff2and Michael T Milano1*AbstractBackground: Standard therapy for metastatic non smallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies ... Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non -small celllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul...
... surgery in patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ... radiotherapy for stage Inon -small celllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana university ... nonsurgical treatment options for stage Inon -small celllung cancer. Oncologist 2008, 13:309-319.41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:Review of Hypofractionated Small...
... energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non -small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse P, ... response to treatment in solid tumors. European Organization forResearch and Treatment of Cancer, National Cancer Insti-tute of the United States, National Cancer Institute of Can-ada. J Natl Cancer ... in non -small celllung cancer Erik P Sulman, Ritsuko Komaki, Ann H Klopp, James D Cox and Joe Y Chang*Address: Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer...
... for Cancer Control and Information Services, National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and 3JCOG lungcancer study group, Thoracic Oncology Division, National Cancer ... III trial comparing two types of consolidationchemotherapy after concurrent chemoradiotherapy for limited-disease smallcelllung cancer. RTrequirements included a total dose of 45 Gy/30 fx ... III trial comparingtwo types of consolidation chemotherapy after concurrentchemoradiotherapy for limited-disease smallcell lung cancer (Figure 1).The primary endpoint of JCOG 0202 was overall...
... Erlangen, Germany). Midway through treatment [median 21st day after start of treatment (19 -24)] and in the sixth week of treatment [median 43rd day after start of treatment (40 - 47)], a follow-up ... megavoltage CT imaging during exter-nal beam radiotherapy for non -small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol Biol Phys 2005, 63:1024-1028.10. ... registration (DR)for adaptive radiotherapy of non -small celllungcancer (NSCLC).Methods: Based on 13 patients with locally advanced NSCLC, CT images acquired at treatment planning, midway and the end...